Downloaded 152 times
Uploaded byDr.Sohel Memon
Jaundice V PharmD by Vineela.N
Jaundice, also known as icterus, is a liver disease characterized by elevated bilirubin levels in the blood. It occurs when bilirubin levels exceed 2mg/dl. There are three main types - prehepatic, intrahepatic, and posthepatic - depending on where the blockage of bilirubin occurs. Signs and symptoms include yellowing of the skin and eyes. Diagnosis involves medical history, physical exam, urine and blood tests, and imaging. Treatment depends on the underlying cause but may include phototherapy, medications to improve bilirubin clearance or surgery to unblock bile ducts. Prevention focuses on limiting potential liver toxins and maintaining vaccination against hepatitis viruses
More Related Content
![Alcoholic liver disease [autosaved]](https://cdn.slidesharecdn.com/ss_thumbnails/alcoholicliverdiseaseautosaved-210106093112-thumbnail.jpg?width=640&height=640&fit=bounds)
![PHARMACOTHERAPY OF Gastric-oesophagal reflux disease [GERD]](https://cdn.slidesharecdn.com/ss_thumbnails/gastric-oesophagalrefluxdiseasegerd-201214173131-thumbnail.jpg?width=640&height=640&fit=bounds)
Similar to Jaundice V PharmD by Vineela.N
Jaundice V PharmD by Vineela.N
- 1.
- 2. Contents of thetopic Definition Classification Signs and symptoms Diagnosis Pathophysiology Prevention Treatment
- 3. Definition : Jaundice, asin the French jaune, refers to the yellow discoloration of the skin. Also known as Icterus Jaundice is a liver disease characterized by elevated levels of bilirubin in the blood termed as hyperbilirubinaemia. Normal range of serum bilirubin concentration is 0.31.3mg/dl Jaundice occurs when bilirubin levels exceeds 2mg/dl
- 4. Introduction toBilirubin : Bilirubin is a orange-yellow pigment formed in the liver by the breakdown of hemoglobin and excreted in bile. Two types of bilirubin : Conjugated and Unconjugated bilirubin Sources of Bilirubin : • Catabolism of heme of hemoglobin (80-85%) • Non-hemoglobin heme containing pigments such as myoglobin, catalase and cytochromes
- 5. Conjugated Bilirubin Unconjugated Bilirubin Watersoluble Water Insoluble It reacts quickly to produce azobilirubin It reacts slowly to produce azobilirubin It produces azobilirubin only in the presence of dye It produces azobilirubin in the absence of dye Known by Direct bilirubin Known by Indirect bilirubin
- 6.
- 8. Types of Jaundice Prehepatic Jaundice Intrahepatic jaundice Post hepatic Jaundice
- 10. Type of Jaundice Pre-Hepatic Intra-hepatic Post-Hepatic OtherName Hemolytic jaundice Hepatocellular Jaundice Obstructive/ Regurgitation Jaundice Cause Increased hemolysis of erythrocytes Examples Malaria, sickle cell anemia, incompatible blood transfusion Dysfunction of liver Obstruction of bile due to damage to duct – prevents the parenchymal cells passage of bile into intestine Viral infection(hepatitis), poisons and toxins(chloroform, carbon tetrachloride, phosphorus), cirrhosis Gallstones, cancer of pancreas, gall bladder and bile duct
- 11. Type of Jaundice Pre-Hepatic Intra-hepatic Post-Hepatic Biochemical characteristics serum unconjugated bilirubin serum conjugated and unconjugated bilirubin,SGPT and SGOT Serum conjugated bilirubin and ALP Clinical manifestations Dark brown color stools Nausea and anorexia Nausea; GI pain and clay colored feces Absent Absent Increased Increased Stercobilinogen Increased content Urobilinogen content Increased
- 13.
- 14. Common Drugs AssociatedWith Hyperbilirubinemia HEPATOCELLULAR CAUSES • • • • • • • • • • • Acetominophen Alcohol Amiodarone Azulfidine Carbenicillin Clindamycin Colchicine Cyclophosphamide Diltiazem Ketoconazole Methyldopa • • • • • • • • • • Niacin Nifedipine NSAIDs Propylthiouracil Pyridium Pyrazinamide Quinidine Rifampicin Salicylates Verapamil
- 15. Common Drugs AssociatedWith Hyperbilirubinemia CHOLESTATIC CAUSES Amitriptyline Androgenic steroids (B) Atenolol Augmentin Azathioprine Bactrim (D) Benzodiazeprines Captopril Carbamazole Chlordiazepoxide (D)) Clofibrate Coumadin Cyclosporine Danazol (B) Dapsone Disopyramide Erythromycin Estrogens (B) Ethambutol Floxuridine 5-Flucytosine Fluoroquinolones Griseofulvin Haloperidol (D) Labetolol Nicotinic acid NSAIDs Penicillins Phenobarbital Phenothiazines (D) Phenytoin Tamoxifen Tegretol Thiabendazole (D) Thiazides Thiouracil Tolbutamide (D) Tricyclics (D) Verapamil Zidovudine
- 16. Etiopathogenesis 1. 2. 3. 4. 5. Increased bilirubin production Reduced bilirubinuptake by hepatic cells Disrupted intracellular conjugation Disrupted secretion of bilirubin into bile canaliculi Intra/extra-hepatic bile duct obstruction Lead to increases in free (unconj.) bilirubin Result in rise in conj. bilirubin levels
- 17. 1. INCREASED BILIRUBINPRODUCTION (unconj. Hyperbilirubinemia) Hemolysis Increased destruction of RBCs eg sickle cell anemia, thalassemia Drastic increase in the amount of bilirubin produced Unconj. bilirubin levels rise due to liver’s inability to catch up to the increased rate of RBC destruction Prolonged hemolysis may lead to precipitation of bilirubin salts in the gall bladder and biliary network - result in formation of gallstones and conditions such as cholecystitis and biliary obstruction Other Degradation of Hb originating from areas of tissue infarctions and hematomas Ineffective erythropoiesis
- 18. 2. DECREASED HEPATICUPTAKE (unconj. Hyperbilirubinemia) Several drugs have been reported to inhibit bilirubin uptake by the liver e.g. novobiocin, flavopiridol Hepatic cell Plasma Alb Bile B B + GST Alb B :GST B + UDPGA CB UGT1A1 sER MRP2
- 19. 3) DISRUPTED INTRACELLULAR CONJUGATION (unconj.Hyperbilirubinemia) Neonatal jaundice occurs in 50% of newborns fetal bilirubin is eliminated by mother’s liver causes: hepatic mechanisms are not fully developed resulting in decreased ability to conjugate bilirubin rate of bilirubin production is increased due to shorter lifespan of RBCs Acquired disorders hepatitis, cirrhosis impaired liver function
- 21. Crigler-Najjar Syndrome, TypeI (CN-I) recessive allele; mutation-induced loss of conjugating ability in the critical enzyme glucuronosyltransferase CN-II greatly reduced but detectable glucuronosyltransferase activity due to mutation (predominantly recessive); enzymatic activity can be induced by drugs Gilbert’s Syndrome glucuronosyl transferase activity reduced to 1030% of normal; also accompanied by defective bilirubin uptake mechanism
- 22. 4) DISRUPTED SECRETIONOF BILIRUBIN INTO BILE CANALICULI (conj. Hyperbilirubinemia) Dubin–Johnson Syndrome mild conj. hyperbilirubinemia, but can increase with concurrent illness, pregnancy, and use of oral contraceptives; otherwise asymptomatic Inability of hepatocytes to secrete CB after it has formed Due to mutation in the MRP2 gene (autosomal recessive trait) Rotor Syndrome Autosomal recessive condition characterized by increased total bilirubin levels due to a rise in CB Caused by a defect in transport of bilirubin into bile
- 24. 5) Intra/extra-hepatic bileduct obstruction Intra-hepatic Obstruction of bile canaliculi, bile ductules or hepatic ducts Extra-hepatic Obstruction of cystic duct or common bile duct Cholecystitis Obstruction causes backup and reabsorption of CB which results in increased blood levels of CB
- 25. Signs and Symptoms Skin and sclerae - yellow Stool - light colour, clay coloured Dark urine Pain in abdomen Itching Trouble with sleeping Fatigue Swelling Ascites Mental confusion Coma Bleeding
- 26. Diagnosis Medical historyand examination Urine test Liver function and blood tests Imaging tests Liver biopsy
- 27. Medical historyand physical examination Patient interview for - abdominal pain, itchy skin or weight loss malaria or hepatitis A change of colour in your urine and stools history of prolonged alcohol misuse Flu like symptoms Medications Occupation Physical examination : - Yellowish discoloration of eye and skin Swelling of legs, ankle and feet Hepatomegaly
- 28. Urine test: - to measure levels of a substance called urobilinogen - more than normal urobilinogen levels : Pre and Intra hepatic jaundice - Less than normal urobilinogen level : Post hepatic jaundice Liver function and blood tests : Damage to liver releases liver enzymes like SGPT, SGOT and ALP and proteins, this indicates - Hepatitis - Alcoholic liver disease - cirrhosis
- 29. Imaging tests -CT Scan - MRI Scan - Ultrasound Scan - Endoscopic retrograde cholangiopancreatography (ERCP) Used to check for abnormalities inside the liver or bile duct systems. Liver biopsy Used to diagnosis Cirrhosis and liver cancer.
- 31. Jaundice treatment The treatmentgiven to someone with jaundice will depend on what type they have, how serious it is and what caused it. It may include tackling an underlying condition such as malaria and bothersome symptoms, such as itching. For genetic conditions that don't get better, like sickle cell anaemia, a blood transfusion may be given to replenish red blood cells in the body. If the bile duct system is blocked, an operation may be needed to unblock it. During these procedures measures may be taken to help prevent further problems, such as removal of the gallbladder. If the liver is found to be seriously damaged, a transplant may be an option
- 32. Treatment & TherapeuticConsiderations PHOTOTHERAPY Through absorption of the wavelengths at the blue end of the spectrum (blue, green and white light), bilirubin is converted into water-soluble photoisomers. This transformation enhances the molecule’s excretion into bile without conjugation.
- 33. PHENOBARBITAL This drugis not approved by FDA for use in neither adult nor pediatric hyperbilirubinemia patients, due to possibility of significant systemic side-effects. Exact pathway is not known, but it is believed to act as an inducing agent on UDP-glucuronosyl transferase, thereby improving conjugation of bilirubin and its excretion. ALBUMIN A 25% infusion can be used in treating hyperbilirubinemia (esp. due to hemolytic disease). It is used in conjunction with exchange transfusion to bind bilirubin, enhancing its removal.
- 34. CLOFIBRATE (ATROMID-S) Thisdrug has been shown to reduce bilirubin levels via an unknown mechanism. Clofibrate is also associated with increased risk of developing cholelithiasis, cholecystitis, as well as functional liver abnormalities, which can worsen hyperbilirubinemia. PERCUTANEOUS TRANSHEPATIC CHOLANGIOGRAPHY Allows extraction of stones and thus removal of the source of obstruction when present.
- 35. Prevention of Jaundice: • Limit alcohol intake to not more than two drinks a day for men or one drink a day for women. • Avoid exposure to industrial chemicals. • Do not use illegal drugs. • Do not share needles or nasal snorting equipment. • Vaccination : Hepatitis A and Hepatitis B • Maintain healthy body weight.